Valeant Said to Keep Salix After Takeda Deal Falls Apart

Valeant Said to Keep Salix After Takeda Deal Falls Apart


Valeant Pharmaceuticals International Inc. has decided to keep and invest in its gastrointestinal-drugs division after talks to sell the unit to Takeda Pharmaceutical Co. fell apart, according to people familiar with the matter.



from Biotech News